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Abstract 
Objective: To evaluate the potential of multiparametric spectroscopic photoacoustic imaging 
using oxygen saturation, total hemoglobin, and lipid content to differentiate among four different 
breast histologies (normal, hyperplasia, ductal carcinoma in situ (DCIS), and invasive breast car-
cinoma) in a transgenic mouse model of breast cancer development. 
Materials and Methods: Animal studies were approved by the Institutional Administrative Panel 
on Laboratory Animal Care. Mammary glands (n=251) of a transgenic mouse model of breast 
cancer development (FVB/N-Tg(MMTV-PyMT)634Mul) were imaged using B-mode ultrasound and 
spectroscopic photoacoustic imaging, analyzed for oxygen saturation, total hemoglobin, and lipid 
content, and processed for histological analysis. Statistical analysis was performed using one-way 
ANOVA, two-sample t-tests, logistic regression, and ROC analysis. 
Results: Eighty-two normal, 12 hyperplastic, 96 DCIS, and 61 invasive breast carcinoma mammary 
glands were analyzed. Based on spectroscopic photoacoustic imaging, the oxygen saturation of 
hyperplasia (50.6%), DCIS (43.0%), and invasive carcinoma (46.2%) significantly increased com-
pared to normal glands (35.5%, P <0.0001), while both total hemoglobin (P<0.01), and lipid content 
(P<0.0008) significantly decreased with advancing histology. In differentiating normal and hyper-
plasia from DCIS and invasive breast carcinoma, multiparametric imaging of oxygen saturation, 
lipid content, and raw photoacoustic signal at 750 nm provided an AUC value of 0.770.  
Conclusion: Multiparametric spectroscopic photoacoustic imaging is feasible and allows detec-
tion of differences in concentration of tissue chromophores among different histologies in a 
transgenic mouse model of breast cancer development. 
Key words: Photoacoustic Imaging, Breast Cancer, Molecular Imaging, Spectroscopic. 
Introduction 
Breast cancer remains the second deadliest can-
cer in women in the USA with an estimated 232,340 
new cases diagnosed and 39,620 patients dying from 
the disease in 2013 (1). If detected early, usually by 
screening mammography, mortality from breast can-
cer can be decreased by approximately one-fifth (2). 
However, the sensitivity of mammography is often 
decreased in patients with dense breast tissue (sensi-
tivity as low as 30%), resulting in delayed detection 
and worse prognosis (3–5). Therefore, ultrasound is 
currently being explored as a second line, comple-
mentary screening modality in patients with dense 
breast tissue diagnosed on mammography (6). While 
anatomical ultrasound imaging used in combination 
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with mammography can substantially increase the 
detection rates for breast cancer in patients with dense 
breast tissue, its positive predictive value is low (as 
low as 8.7% in a recent study) (6), resulting in many 
unnecessary callbacks and biopsies. Thus, improving 
our ability to non-invasively differentiate benign from 
malignant diseases on ultrasound imaging is critically 
needed to decrease the number of false positive find-
ings in particular for patients with dense breast tissue. 
Photoacoustic imaging is an emerging modality 
that is complementary to ultrasound imaging due to 
shared instrumentation and data processing algo-
rithms. It provides additional tissue information to 
ultrasound imaging by adding quantitative data on 
the molecular composition of the tissue based on op-
tical absorption properties (7,8). The photoacoustic 
effect is the conversion of low fluence, pulsed laser 
irradiation to broadband acoustic waves through 
several physical phenomena, including thermoelastic 
expansion (7,8). In brief, when sufficiently short (<10 
ns) pulsed laser irradiation is absorbed by tissue 
chromophores (the section of a molecule that absorbs 
light) there is localized heating and expansion of the 
environment immediately surrounding the absorber. 
When the heat dissipates, the rapid contraction of the 
environment to its initial state releases broadband 
acoustic transients which can be detected and used to 
form an image, similarly to traditionally used ultra-
sound. Since sound waves, instead of optical signals, 
are released at the site of chromophores, photoacous-
tic imaging provides optical contrast at depths far 
beyond traditional optical modalities (theoretically up 
to 5 cm instead of a few mm) (9,10). 
While several exogenous photoacoustic contrast 
agents including noble metal, plasmonic nanoparti-
cles, iron oxide nanoparticles, carbon nanotubes, and 
dyes are currently being explored as photoacoustic 
contrast agents due to their high optical absorption 
coefficients and thus high imaging signal (8), endog-
enous photoabsorbers such as oxygenated and deox-
ygenated hemoglobin (11), melanin (12), and lipids 
(13) can also act as photoacoustic contrast agents. The 
advantage of leveraging endogenous photoabsorbers 
for photoacoustic imaging is that there is no need for 
administering exogenous contrast agents which 
makes this an immediately clinically translatable mo-
lecular imaging approach. As the optical absorption of 
endogenous photoabsorber substantially changes 
with the optical wavelength,  spectroscopic photoa-
coustic imaging can be used to quantify the photoa-
coustic signals produced by different chromophores 
within the tissues in a concentration dependent 
manner (13–15). Furthermore, the oxygen saturation 
of tissues can be calculated by determining the ratio of 
oxygenated hemoglobin to total hemoglobin (16,17). 
While spectroscopic photoacoustic imaging appears 
to be a promising non-invasive molecular imaging 
modality, no animal or clinical studies have been 
performed to determine how spectroscopic photoa-
coustic imaging could be used to characterize focal 
diseases such as different breast lesions. Whether dif-
ferent breast lesions have reliable changes in endog-
enous photoabsorber concentrations, and whether 
these changes are significant enough to be detected 
using spectroscopic photoacoustic imaging has yet to 
be determined. 
The purpose of our study was to evaluate the 
potential of multiparametric spectroscopic photoa-
coustic imaging using oxygen saturation, total hemo-
globin, and lipid content to differentiate among four 
different breast histologies (normal, hyperplasia, 
ductal carcinoma in situ (DCIS), and invasive breast 
carcinoma) in a transgenic mouse model of breast 
cancer development. 
Materials and Methods 
Transgenic Animal Model of Breast Cancer 
Development 
All procedures involving the use of laboratory 
animals for this study were approved by the Institu-
tional Administrative Panel on Laboratory Animal 
Care. A well characterized transgenic mouse model of 
breast cancer development (FVB/N-Tg(MMTV- 
PyMT)634Mul) was used for this study (18,19). In this 
mouse model, breast tissue progresses through four 
distinct histological stages from normal mammary 
tissues, through hyperplasia, to DCIS, and finally in-
vasive breast carcinoma. Individual mice may have 
mammary glands at various stages of disease pro-
gression. A total of 27 female mice (19 transgene posi-
tive, 8 transgene negative, each with 10 mammary 
glands; total of 270 mammary glands; Figure 1) with 
various ages (mean age, 7 weeks; range, 4-10 weeks) 
and hence various stages of disease progression were 
examined in this study.  
Combined Ultrasound and Photoacoustic 
Imaging of Mammary Glands 
During imaging sessions, all animals were kept 
anesthetized with 2% isoflurane in oxygen at 2 L/min 
on a heated stage to maintain body temperature at 37 
ºC. Pre-warmed, clear, non-colored ultrasound gel 
was used to couple the ultrasound transducer to the 
animal. In all mice, transverse two-dimensional 
B-mode ultrasound and photoacoustic images of all 
ten mammary glands were collected at the level of the 
maximal gland diameter using a dedicated 
small-animal, high-resolution ultrasound imaging 
system (Vevo2100 / Vevo LAZR, VisualSonics, To- Theranostics 2014, Vol. 4, Issue 11 
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ronto, Canada). Co-registered ultrasound and photo-
acoustic images were obtained of each mammary 
gland with a 21 MHz transducer (lateral and axial 
resolution of 165 and 74 µm, respectively), fixed to a 
rail system to maintain constant position. Photoa-
coustic images were acquired over 17 wavelengths 
(700-860 nm in 10 nm increments) with  an average 
fluence of 10 mJ/cm2 as measured by a power meter 
(Ophir Photonics Group, Utah, USA). The surface of 
the skin was always placed at a distance of 9 mm 
compared to the surface of the transducer to allow for 
homogenous light illumination of the mammary 
gland tissues because in the photoacoustic imaging 
system used in this study the optical fibers emit light 
from either side of the transducer and the intersection 
of the light paths occurs at a depth level of 9 mm. 
To determine whether differences in raw photo-
acoustic signal can also be used to differentiate be-
tween different breast tissue histologies, raw photoa-
coustic signal intensities were also obtained in addi-
tion to spectroscopically resolved tissue chromo-
phores concentrations. The raw photoacoustic signal 
intensity was measured at three wavelengths: 750 nm 
(the peak absorption for both deoxygenated hemo-
globin and lipid), 800 nm (oxygenated and deoxy-
genated hemoglobin have similar absorption proper-
ties), and 850 nm (oxygenated hemoglobin dominates 
absorption) (20,21). To allow for intra-animal and in-
ter-animal comparisons, all ultrasound and photoa-
coustic imaging settings were kept constant 
throughout the experiments. 
Image Analysis of Photoacoustic Data Sets 
A MATLAB-based, spectroscopic approach was 
used to define the average oxygen saturation and li-
pid content of each gland as described in detail else-
where  (10,22). Briefly, the co-registered transverse 
B-mode ultrasound images were used to define the 
region of interest (ROI) containing the entire mam-
mary glands in a random order by one researcher 
experienced with both ultrasound and photoacoustic 
imaging. The researcher was blinded to the age and 
histology results of the mammary glands. Using 
photoacoustic signal from images acquired at 800 nm 
(the isobestic absorption point of oxygenated and 
deoxygenated hemoglobin) any pixels within the ROI 
that had low signal amplitudes indistinguishable 
from background signals were eliminated from the 
spectroscopic calculation as previously described (22). 
Glands in which 50% or more of the pixels had insuf-
ficient signal were eliminated and not included in the 
study results (n=19/270; 7%). 
Assuming the optical absorption in mammary 
glands is derived primarily from three endogenous 
photoabsorbers, oxygenated hemoglobin (Hb), deox-
ygenated hemoglobin (deHb), and lipids (L), the lo-
calized absorption coefficient (µa) can be considered 
the sum of the three individual absorption coeffi-
cients. The absorption coefficient (μa(λ,r)) is defined as 
the product of the molar extinction (Ɛ) and the con-
centration (C) of the photoabsorber as described 
(10,22), providing the following equation (1). 
μa(λ,r)=CHb(r) Ɛ Hb(λ)+CdeHb(r) Ɛ deHb(λ)+CL(r) Ɛ L(λ)  
…(1) 
A linear least squares regression was used to 
determine the concentration of oxygenated and de-
oxygenated hemoglobin, and of lipids in relative but 
arbitrary units (a.u.) within the ROI based on the as-
sumption that the photoacoustic signal (known vari-
able as measured in the experiment) is proportional to 
the molar extinction coefficient (known variable from 
the literature (20,21)) times the concentration of the 
individual photoabsorbers (unknown variable). Any 
pixels that resulted in negative calculated concentra-
tions (a known limitation of least squares error re-
gression methods (22)) of photoabsorbers were elim-
inated from the average. Other parameters, such as 
fluence and the Grüneisen parameter (7,10), were as-
sumed to be constant due to the superficial location of 
mammary glands at less than 2 mm depth in this 
mouse model, the constant fluence applied, and the 
similarity of tissues being imaged. Oxygen saturation 
was calculated by taking the concentration of the ox-
ygenated hemoglobin and dividing it by the sum of 
the oxygenated and deoxygenated concentrations 
times 100%. Please note that these oxygen saturation 
values vary from clinical oxygen saturation meas-
urements obtained by a pulse-oximeter which 
measures an optical absorbance ratio between two 
wavelengths of light which is then compared to a 
calibration curve to provide oxygen saturation (23). 
The measure of oxygen saturation provided by the 
technique in this study corresponds to the ratio of 
concentrations of oxyhemoglobin (4/4 oxygens bound 
to hemoglobin) to deoxyhemoglobin (approximately 
0/4 oxygens bound to hemoglobin) determined from 
the molar absorption coefficients over multiple 
wavelengths (10, 22, 24). A flow chart illustrating the 
imaging and image analysis workflow is provided in 
Figure 1. 
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Figure 1. Flow chart summarizes the workflow of spectral photoacoustic imaging data set acquisition and data analysis in transgenic mice. (1) Co-registered transverse 
ultrasound and photoacoustic images at 17 wavelengths were collected in a single plane at the level of the maximal diameter of the mammary gland (dotted blue line) in each of 
the ten mammary glands in a transgenic mouse model of breast cancer development. (2) A linear least squares regression was performed using known absorption spectra of tissue 
chromophores in order to spectroscopically resolve the concentrations of individual photoabsorbers (oxygenated and deoxygenated hemoglobin and lipid). (3) In parallel, (2), 
regions of interest (ROI) were drawn on the ultrasound images, while the raw photoacoustic signal intensities measurements were analyzed to ensure sufficient signal for quality 
spectral analysis. (4) The quality-controlled ROI and spectrally processed images were then combined to provide (5) maps of total hemoglobin and lipid content and the oxygen 
saturation within the glands. 
 
Ex Vivo Analysis of Mammary Glands 
After combined ultrasound and photoacoustic 
imaging, all 251 mammary glands were harvested for 
ex vivo  analysis. Each gland was fixed in 4% para-
formaldehyde, embedded in paraffin and cut into 5 
μm  sections  for  hematoxylin-eosin (H&E) staining 
according to standard protocols (19). Histological di-
agnoses (normal mammary gland, hyperplasia, DCIS, 
or invasive breast carcinoma) were determined by the 
most advanced stage present in the gland in random 
order rendered by two readers in consensus familiar 
with this mouse model and blinded to both the age of 
the animals and imaging results. Normal mammary 
glands were characterized by high proportion of fat 
with few, organized ductal epithelium. Mammary 
hyperplasia was distinguished by an increased vol-
ume of ductal epithelium that was still organized in 
an overall fatty gland. DCIS was defined as an in-
crease of acinar cell clusters with completely ex-
panded ductal proliferation. Findings were inter-
preted as invasive carcinoma on the basis of large 
solid expansile growth that infiltrates and entraps 
adjacent tissue such as fat as described previously in 
more detail (18,19). 
To analyze lipid content in the mammary glands, 
four glands from each disease state (normal, hyper-
plasia, DCIS, invasive carcinoma) were also frozen 
into optimal cutting temperature compound and 
sliced into 12 µm sections following standard proto-
cols (25). In brief, sections were washed with phos-
phate buffered saline, and stained for 6 min with 
freshly prepared Oil Red O (ORO) stain in 60% iso-
propanol which had been filtered through a 0.45 µm 
syringe filter. Next, the slides were rinsed for 2 min 
with a 60% isopropanol solution to destain the slides, 
followed by a 30-second nuclear stain with hematox-
ylin. Slides were then rinsed for 30 min under gently 
running tap water and mounted with an aqueous 
mounting medium. Slides were digitized using a 
Nanozoomer (Hamamatsu, Japan) at 40x. For quanti-
tative assessment of the % area lipid content, images 
of five adjacent 20X sections from each gland were 
captured and, using RGB thresholding, the total area 
of red staining was measured compared to the total 
area of tissue.  Theranostics 2014, Vol. 4, Issue 11 
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Assessment of Total Hemoglobin 
Concentration in Blood 
To assess relative changes of total hemoglobin 
concentrations in the blood of mice with invasive 
breast cancer versus mice with normal breast tissue, 
blood was collected using submandibular bleed as 
described previously (26) and complete blood counts 
(CBC) were provided by a veterinary diagnostic la-
boratory using a standard hematology analyzer 
(XT-2000iV, Sysmex, Lincolnshire, Illinois, USA). In 
brief, six, 12-week-old transgenic mice with invasive 
carcinoma and six littermate transgene negative con-
trol mice were anesthetized using 2% isoflurane in 
oxygen at 2 L/min on a heated stage to maintain body 
temperature at 37 ºC. A 5 mm lancet was used to 
puncture at the junction of the orbital veins and the 
submandibular vein and 0.2 -  0.4 ml of blood was 
collected into an ethylenediaminetetraacetic acid 
spray-coated vial. A routine CBC analysis was per-
formed by the Veterinary Service Center Diagnostic 
Lab using a standardized protocol. 
Statistical Analysis 
Continuous measurements were summarized as 
means ± standard error of the means. All statistical 
comparisons used one-way ANOVA tests to deter-
mine if differences among the four histological groups 
existed; individual two-sample t-tests were used to 
compare any two histological groups. The predictive 
value of individual and combined tissue chromo-
phores was evaluated by estimating the area under 
the receiver operating characteristic (ROC) curve 
(AUC) for differentiating dichotomized outcomes of 
interest such as normal vs. other histologies or nor-
mal/hyperplasia vs. DCIS/invasive breast cancer. 
The 95% confidence intervals for AUC were also pro-
vided. Tissue spectroscopic parameters were com-
bined to boost the discriminating power by fitting 
multivariate logistic regression models in which the 
linear combination of the selected biomarkers was 
estimated. All statistical analysis was performed us-
ing R (2.10.1) and Prism GraphPad software. A 
two-sided  P-value of less than 0.05 was considered 
indicative of a signiﬁcant difference. 
Results 
In Vivo Spectroscopic Photoacoustic Imaging of 
Breast Tissue 
Total Hemoglobin and Oxygen saturation 
In total, 251 mammary glands were imaged, an-
alyzed, and classified into four histologies: normal 
(n=82, 77 from transgene negative controls and 5 from 
transgene positive mice), hyperplasia (n=12), DCIS 
(n=96), and invasive carcinoma (n=61) (Figure 2). 
Based on spectroscopic photoacoustic imaging, the 
total hemoglobin levels were 527.4 a.u. ± 20.5 a.u. in 
normal tissue, 590.5 a.u. ± 42.3 a.u. in hyperplasia, 
472.2 a.u. ± 9.1 a.u. in DCIS, and 477.9 a.u. ± 14.0 a.u. 
in invasive carcinoma. Normal (P = 0.01 and 0.007, 
respectively) and hyperplasia (P  <0.0001 and 0.002, 
respectively) glands had significantly more hemoglo-
bin content than DCIS and invasive carcinoma. Values 
between normal and hyperplasia were not signifi-
cantly different (P = 0.26) (Table 1). Total hemoglobin 
concentrations in the blood of mice with normal 
breast cancer (13.5 ± 0.4 mg/dL) was significantly 
higher (P  <0.01) compared to mice with invasive 
breast tissue (10.9 ± 0.6 mg/dL). 
The oxygen saturation in hyperplasia (50.6% ± 
1.9%; P <0.0001), DCIS (43.0% ± 0.9%; P <0.0001), and 
invasive carcinoma (46.2% ± 1.1%; P <0.0001) signifi-
cantly increased compared to normal mammary tis-
sues (35.5% ± 0.6%). The oxygen saturation in hyper-
plasia was significantly higher compared to DCIS (P = 
0.005). On histology, there were no foci of necrosis in 
invasive cancer or in any of the other histologies. 
Lipid Content 
Based on spectroscopic photoacoustic imaging, 
the lipid content for the four histologies were 75.4 a.u. 
± 3.4 a.u. (normal), 64.5 a.u. ± 6.6 a.u. (hyperplasia), 
60.4 a.u ± 2.5 a.u. (DCIS), and 55.5 a.u. ± 2.2 a.u. (in-
vasive carcinoma; Table 1). The lipid content de-
creased significantly (P  <0.0008) between nor-
mal/hyperplasia versus DCIS/invasive carcinoma. 
On histology, the lipid content significantly (P < 0.01) 
decreased with disease progression from normal to 
invasive carcinoma. In normal and hyperplastic breast 
tissue the % area lipid was 68.3% ± 4.0% and 49.8% ± 
5.5%, respectively; whereas in glands with DCIS and 
invasive carcinoma, respectively, the area percent of 
lipid was 8.7% ± 1.6% and 4.1% ± 0.8% (Figure 3). 
 
Table 1. Summary of spectroscopic photoacoustic imaging signals 
of total hemoglobin, oxygen saturation, and lipid content in four 
histologies (normal, hyperplasia, ductal carcinoma in situ, and 
invasive carcinoma) in a transgenic mouse model of breast cancer 
development. 
Histology  Total Hemoglobin 
± SEM (a.u.) 
Oxygen Satura-
tion ± SEM (%) 
Lipid Content 
± SEM (a.u.) 
Normal  527.4 ± 20.5  35.5 ± 0.6  75.4 ± 3.4 
Hyperplasia  590.5 ± 42.3  50.6 ± 1.9 *  64.5 ± 6.6 
Ductal Carcinoma In 
situ 
472.2 ± 9.1 *^  43.0 ± 0.9 *^  60.4 ± 2.5 * 
Invasive Carcinoma  477.9 ± 14.0 *^  46.2 ± 1.1*’  55.5 ± 2.2 * 
*Statistically significant difference (P < 0.01) as compared to normal. ^Statistically 
significant difference (P < 0.01) as compared to hyperplasia. ‘Statistically significant 
difference (P< 0.01) as compared to ductal carcinoma in situ. 
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Figure 2. Representative transverse B-mode ultrasound images and spectroscopic photoacoustic images (raw photoacoustic signal intensity at 750 nm, oxygen saturation (sO2), 
total hemoglobin, and lipid content) of four histologies (normal, hyperplasia, DCIS, and invasive carcinoma) from distinct animals of a transgenic mouse model of breast cancer 
progression. Regions of interest were outlined in red on B-mode images. Scale bar in ultrasound images represents 2 mm. Corresponding hematoxylin and eosin (H&E) stained 
histology findings of normal, hyperplasia, DCIS, and invasive carcinoma are also shown. Scale bars represent 1 mm in 5X images and 200 µm in magnified (20X) images. Boxes on 
histology images show area of magnification for 20X images. 
  Theranostics 2014, Vol. 4, Issue 11 
 
http://www.thno.org 
1068 
 
Figure 3. Representative photomicrographs of mouse mammary glands with four different histologies including normal, hyperplasia, ductal carcinoma in situ, and invasive breast 
cancer stained for lipids using Oil Red O (ORO) (red); the cell nuclei were counterstained with hematoxylin (blue). Note that there was substantial decrease of fat when 
mammary glands progressed into invasive breast cancer. Scale bars represent 250 µm in 5X images and 50 µm in magnified (20X) images. Boxes on histology images show area 
of magnification for 20X images. Box plot showing statistically significant (P <0.01) decrease in gland lipid content with disease progression from normal to invasive carcinoma. 
Note: following Tukey rules, each box edge in the plot represents the 25th and 75th quartiles, the center line represents the median, and the vertical lines outside the box 
represent the largest data point up to the 75th quartile plus 1.5 times the interquartile range and the smallest value down to the 25th quartile minus 1.5 times the interquartile 
range respectively. Any data outside these lines represent statistical outliers (triangles). 
 
Raw Photoacoustic Signal Intensity 
The average raw photoacoustic signal intensity 
at 750 nm was measured as follows: normal (364.8 a.u. 
± 14.0 a.u.), hyperplasia (333.7 a.u. ± 24.8 a.u.), DCIS 
(281.8 a.u. ± 5.3 a.u), and invasive carcinoma (280.0 
a.u. ± 9.5 a.u.). The raw photoacoustic imaging signal 
in normal and hyperplasia glands were higher com-
pared to DCIS and invasive carcinoma (P <0.001). The 
raw photoacoustic signal intensity at 800 nm was 
measured as follows: normal (242.6 a.u. ± 9.4 a.u.), 
hyperplasia (264.5 a.u. ± 21.4 a.u.), DCIS (223.5 a.u. ± 
6.4 a.u.), and invasive carcinoma (231.5 a.u. ± 9.0 a.u). 
No significant difference (P  = 0.16) in raw photoa-
coustic signal intensity at 800 nm was found as ex-
pected because oxygenated and deoxygenated hemo-
globin have similar absorption properties at this 
wavelength. The raw photoacoustic signal intensity at 
850 nm was as follows: normal (248.2 a.u. ± 10.2 a.u.), 
hyperplasia (297.6 a.u. ± 33.2 a.u.), DCIS (225.3 a.u. ± 
5.2 a.u.), and invasive carcinoma (236.1 a.u. ± 7.7 a.u.). 
The raw photoacoustic imaging signal at 850 nm in 
hyperplasia was significantly higher compared to 
those measured in mammary glands with other his-
tologies (P = 0.008). 
Multiparametric Analysis of Spectral 
Photoacoustic Images for Histological 
Classification of Mammary Glands 
In order to determine feasibility of using differ-
ent spectroscopically resolved tissue chromophores to 
help distinguish the four different breast histologies, 
ROC curves for various combinations of the calcu-
lated spectroscopic categories were created for two 
different groupings of disease stage: either normal 
glands versus combined hyperplasia/DCIS/invasive 
carcinoma or normal/hyperplasia versus 
DCIS/invasive carcinoma (Table 2). The individual 
parameter with the highest AUC value (0.805 and 
0.736 respective of group) was oxygen saturation. The 
combination of parameters that yielded highest AUC 
values was oxygen  saturation, lipid concentration, 
and raw PA signal at 750 nm with an AUC of 0.822 
and 0.770 respective of grouping. 
 
 
 
Table 2.  Summary of AUC values (including 95% confidence 
intervals) for single and combined photoacoustic parameters in 
differentiating  either normal mammary gland histology versus 
hyperplasia/DCIS/invasive carcinoma or in differentiating nor-
mal/hyperplasia versus DCIS/invasive carcinoma. 
Parameters  Normal vs. Others 
(95% CI) 
Normal/Hyperplasia 
vs. DCIS/Invasive Car-
cinoma (95% CI) 
sO2, Lipid, and PA750  0.822 (0.772, 0.873)  0.770 (0.711, 0.829) 
sO2, Lipid, Hemoglobin  0.822 (0.772, 0.873)  0.765 (0.705, 0.824) 
sO2, Lipid, PA750, He-
moglobin 
0.822 (0.771, 0.872)  0.763 (0.704, 0.823) 
sO2, PA750  0.820 (0.769, 0.872)  0.763 (0.703, 0.822) 
sO2, PA750, Hemoglobin  0.819 (0.768, 0.871)  0.763 (0.703, 0.822) 
sO2, Lipid  0.819 (0.768, 0.870)  0.755 (0.694, 0.815) 
sO2  0.805 (0.752, 0.859)  0.736 (0.673, 0.789) 
PA750  0.653 (0.576, 0.729)  0.659 (0.586, 0.732) 
Lipid  0.640 (0.567, 0.713)  0.624 (0.551, 0.696) 
PA800  0.527 (0.444, 0.611)  0.561 (0.482, 0.640) 
Hemoglobin  0.512 (0.428, 0.596)  0.552 (0.473, 0.631) 
PA850  0.511 (0.427, 0.595)  0.533 (0.453, 0.612) 
Note.- sO2 – Oxygen saturation, Lipid – lipid content, - Hemoglobin – total hemo-
globin, PA750 – raw photoacoustic signal intensity at 750 nm, PA800 – raw photoa-
coustic signal intensity at 800 nm, PA850 – raw photoacoustic signal intensity at 850 
nm. 
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Discussion 
This study showed the feasibility of using mul-
tiparametric spectroscopic photoacoustic imaging to 
differentiate among groupings of various breast his-
tologies (defined as either clinically actionable or 
non-actionable) in a transgenic mouse model of breast 
cancer development. Oxygen saturation as a single 
parameter as well as a combination of oxygen satura-
tion, lipid content, and raw photoacoustic signal at 
750 nm performed best for classifying histologies. 
Photoacoustic imaging is an emerging imaging 
approach which is currently being translated from 
preclinical to clinical applications in breast imaging 
through the development of new clinical grade pho-
toacoustic systems (27–29). Specifically, spectroscopic 
photoacoustic imaging allows quantification of en-
dogenous photoabsorbers such as hemoglobin or lipid 
that could be leveraged for non-invasive characteri-
zation of focal breast lesions (11-13). To validate this 
technique, spectroscopic photoacoustic imaging has 
been compared to standard laboratory CO-oximeter 
measurements as the gold standard in an initial in 
vitro study. In that study it has been shown that spec-
troscopic photoacoustic imaging is accurate to within 
a few percent in the quantification of oxygen satura-
tion of hemoglobin (30). Subsequent in vivo  meas-
urements in sheep comparing spectroscopic meas-
urements versus direct blood sample readings using a 
CO-oximeter as the gold standard further confirmed 
ability of the spectroscopic photoacoustics to measure 
oxygen saturation (31). Additional in vivo studies used 
spectroscopic photoacoustic imaging to assess total 
hemoglobin concentration and oxygenation satura-
tion versus histological findings in mice including an 
orthotopic U87 human glioblastoma model (16)  as 
well as in subcutaneous murine (17) and human (22) 
breast cancer models. Furthermore, it has been 
demonstrated that spectroscopic photoacoustic im-
aging allows visualization of areas of hypoxia in an 
animal model of pancreatic cancer which correlated 
well with immunohistochemical hypoxia staining 
(32). Other tissue chromophores, such as lipids, have 
also been imaged with spectroscopic photoacoustic 
imaging and compared to histology both in an ather-
osclerosis models in rabbits in vivo (13) and in excised 
human atherosclerotic aortas in an ex vivo study (33). 
In our study, we explored the potential of multipar-
ametric spectroscopic photoacoustic imaging for 
characterization of various pathologies in breast can-
cer development in a transgenic mouse model which 
could eventually be helpful to further characterize 
sonographically detected lesions in patients under-
going breast ultrasound. 
We found that oxygen saturation as a single pa-
rameter performed best to differentiate clinically 
non-actionable (normal/hyperplasia) versus clinically 
actionable (DCIS and invasive breast carcinoma) 
findings with an AUC value of 0.74. Considering hy-
perplasia also an actionable precursor lesion in this 
transgenic mouse model (because hyperplasia always 
progresses into DCIS and eventually to invasive car-
cinoma in these mice) the AUC value further in-
creased to 0.81. 
Oxygen saturation was elevated at the hyper-
plasia stage compared to normal tissue which may be 
explained by a metabolic switch to a more anaerobic 
metabolism (e.g., the Warburg effect) (34,35) already 
at the hyperplasia stage in this transgenic mouse 
model, leaving more oxygen bound to hemoglobin in 
the blood. Oxygen saturation levels were also in-
creased in DCIS and further remained elevated in 
invasive carcinoma compared to normal tissue. In 
particular, we did not observe hypoxia in the invasive 
cancer cases in our study and histological analysis did 
not show areas of necrosis. Hypoxia and or necrosis 
are typical findings of more advanced cancer cases 
which we did not include in our study. 
Another observation in our study was that spec-
troscopic photoacoustic imaging showed decreased 
levels of total hemoglobin in DCIS and invasive car-
cinoma compared to normal tissue and hyperplasia. 
This was an unexpected finding since vascularity is 
increased both in DCIS and invasive carcinoma in this 
mouse model (36) and an increased number of vessels 
would suggest an increased concentration of 
hemoglobin in the tissue. However, since total hemo-
globin as measured by spectroscopic photoacoustic 
imaging not only depends on the number of vessels in 
the imaging plane but also on the hemoglobin con-
centration of the blood perfusing those vessels, the 
observed trend may partially be explained by de-
creased blood hemoglobin concentrations in mice 
with invasive carcinoma as confirmed by CBC meas-
urements in our study.  
Another parameter examined in our study was 
the lipid content of each gland, which was the second 
best individual classifier of disease. Despite the sig-
nificantly higher optical absorption coefficients of 
hemoglobins compared to lipid (fat), lipid maintains a 
distinctive spectrum in the range of 680-900 nm with 
two peaks at 762 and 830 nm (37). This spectrum, 
along with a high proportion of fat (mammary glands 
can contain up to 87% by mass of lipids (38) and 
confirmed in this study), allows detection via spec-
troscopic analysis. The overall observed decrease in 
lipid content in breast cancer development in our 
study was due to the replacement of fat tissue by solid 
tumor components with the mammary glands pro-
gressing towards invasive cancer. This was further 
confirmed by lipid staining which showed a substan- Theranostics 2014, Vol. 4, Issue 11 
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tial decrease in the percent area lipid in the mammary 
glands at more advanced stages. 
There are several recognized limitations of our 
study. First, while the transgenic model of breast 
cancer development used in our study recapitulates 
disease progression in patients with various histolog-
ical precursor stages including hyperplasia and DCIS, 
which is substantially closer to human diseases than 
other animal models such as subcutaneously or or-
thotopically implanted breast cancer, this model still 
varies in some aspects compared to human disease. 
For example, the hyperplasia disease state is transi-
tional and rapidly progresses to DCIS and invasive 
cancer, whereas hyperplasia in humans is not always 
considered precancerous and actually may not always 
progress to cancer (39,40).  Therefore, the noticeable 
differences  in spectroscopically resolved parameters 
(i.e. oxygen saturation) found in this study may not be 
detectable in different types of hyperplasia in hu-
mans. Another limitation of the animal model is that 
disease development is often focal within the mam-
mary gland with areas of normal gland tissue (or 
other histologies) interspersed. While focal areas be-
come more confluent with disease progression, 
B-mode ultrasound imaging still does not allow dif-
ferentiation between different histological foci based 
on morphological criteria. Therefore, for quantitative 
assessment of spectral photoacoustic signatures, we 
chose to draw ROIs over the entire glands in all ani-
mals, which may have resulted in averaging of im-
aging signals since some glands may have contained 
more than one histological entity and calculated val-
ues may, therefore, either under-  or overestimate 
values for the four different histologies. Therefore, 
our findings need to be eventually validated in pa-
tients where B-mode  ultrasound shows distinct le-
sions that can then be further characterized by spec-
tral photoacoustic imaging by drawing regions of 
interest around the focal lesions as outlined by the 
ultrasound imaging. Another limitation of the mouse 
model refers to the relatively small number of hyper-
plasia cases imaged in our study as hyperplasia only 
persists for a few days in this model before progress-
ing to DCIS. Also, this mouse model does not develop 
other benign lesions beyond hyperplasia such as for 
example fibroadenoma. 
Second, quantitative spectroscopic photoacoustic 
imaging has intrinsic limitations due to depth and 
wavelength dependent light absorption. Commonly 
used models to address this limitation include fluence 
correction via Monte Carlo modeling and other 
methods for depth and wavelength dependent atten-
uation of light (10,22)  for which this study did not 
account for since all breast tissues were scanned at a 
similar depth level of only 2 mm or less. 
Third, the images in this study were limited to 
two-dimensional planes, which may not accurately 
portray disease status in the entire gland. 
In conclusion, the results of our study suggest 
that multiparametric spectroscopic photoacoustic 
imaging is feasible and allows differentiating normal 
and hyperplasia from DCIS and invasive breast car-
cinoma in a transgenic mouse model of breast cancer 
development with reasonable diagnostic accuracy. 
Future studies in patients using clinical grade photo-
acoustic imaging devices currently under develop-
ment are needed to assess the clinical value of spec-
troscopic photoacoustic imaging to non-invasively 
characterize sonographically detected focal breast 
lesions. This complementary technique which could 
be added to standard ultrasound during the same 
exam may help further increase diagnostic accuracy of 
ultrasound in breast cancer imaging. 
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